Drosophila as a model to explore secondary injury cascades after traumatic brain injury
- PMID: 34463269
- PMCID: PMC8458259
- DOI: 10.1016/j.biopha.2021.112079
Drosophila as a model to explore secondary injury cascades after traumatic brain injury
Abstract
Drosophilae are emerging as a valuable model to study traumatic brain injury (TBI)-induced secondary injury cascades that drive persisting neuroinflammation and neurodegenerative pathology that imposes significant risk for long-term neurological deficits. As in mammals, TBI in Drosophila triggers axonal injury, metabolic crisis, oxidative stress, and a robust innate immune response. Subsequent neurodegeneration stresses quality control systems and perpetuates an environment for neuroprotection, regeneration, and delayed cell death via highly conserved cell signaling pathways. Fly injury models continue to be developed and validated for both whole-body and head-specific injury to isolate, evaluate, and modulate these parallel pathways. In conjunction with powerful genetic tools, the ability for longitudinal evaluation, and associated neurological deficits that can be tested with established behavioral tasks, Drosophilae are an attractive model to explore secondary injury cascades and therapeutic intervention after TBI. Here, we review similarities and differences between mammalian and fly pathophysiology and highlight strategies for their use in translational neurotrauma research.
Keywords: Apoptosis; Drosophila; Inflammation; Innate immunity; Mitochondria; Neurodegeneration; Oxidative stress; Secondary injury; Traumatic brain injury.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Conflict of interest statement
Competing financial interests: The authors declare no biomedical financial interests or potential conflicts of interest.
Figures
References
-
- Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, Agrawal A, Adeleye AO, Shrime MG, Rubiano AM, Rosenfeld JV, Park KB. Estimating the global incidence of traumatic brain injury. Journal of neurosurgery. 2018:1–18. Epub 2018/04/28. doi: 10.3171/2017.10.Jns17352. PubMed PMID: 29701556. - DOI - PubMed
-
- de la Tremblaye PB, O'Neil DA, LaPorte MJ, Cheng JP, Beitchman JA, Thomas TC, Bondi CO, Kline AE. Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation. Neurosci Biobehav Rev. 2018;85:160–75. Epub 2017/06/04. doi: 10.1016/j.neubiorev.2017.05.022. PubMed PMID: 28576511; PMCID: PMC5709241. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
